Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Phillips

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Science Translational Medicine|May 3, 2019
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autismKaren J Parker, Ozge Oztan, Robin A Libove, et al.
Plos One|July 23, 2015
Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with AutismDean S Carson, Joseph P Garner, Shellie A Hyde, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial EndpointsLatha Valluripalli Soorya, Camille W Brune, Cristan A Farmer, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Science Translational Medicine|May 3, 2019
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autismKaren J Parker, Ozge Oztan, Robin A Libove, et al.
Plos One|July 23, 2015
Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with AutismDean S Carson, Joseph P Garner, Shellie A Hyde, et al.
American Journal on Intellectual and Developmental Disabilities|August 26, 2025
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial EndpointsLatha Valluripalli Soorya, Camille W Brune, Cristan A Farmer, et al.
Pageof 7